Task: Answer the multiple-choice question.
Question: Which drug exhibits a -10.258% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) CCCc1cc(=O)oc2cc(OCC(=O)Nc3ccc4c(c3)OCCO4)ccc12
b.) CC1CCN(c2cc(N3CCOCC3)c([N+](=O)[O-])cc2F)CC1
c.) CCn1c(SCC(=O)NC(C)(C)C)nnc1-c1ccoc1C
Answer: b. CC1CCN(c2cc(N3CCOCC3)c([N+](=O)[O-])cc2F)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CCN(c2cc(N3CCOCC3)c([N+](=O)[O-])cc2F)CC1
CC1CCN(c2cc(N3CCOCC3)c([N+](=O)[O-])cc2F)CC1
4-[4-fluoro-5-(4-methylpiperidin-1-yl)-2-nitrophenyl]morpholine